UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 424

Sortiert nach

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (7), p.djw295

2017

Volltextzugriff (PDF)

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes

American journal of obstetrics and gynecology, 2007-11, Vol.197 (5), p.457.e1-457.e21

2007

Volltextzugriff (PDF)

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Blood, 2012-03, Vol.119 (9), p.2135-2140

2012

Volltextzugriff (PDF)

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Blood, 2010-07, Vol.116 (2), p.280-286

2010

Volltextzugriff (PDF)

A cross-sectional analysis of cardiovascular disease in the hemophilia population

Blood advances, 2018-06, Vol.2 (11), p.1325-1333

2018

Volltextzugriff (PDF)

Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy

Blood advances, 2020-01, Vol.4 (1), p.100-105

2020

Volltextzugriff (PDF)

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage

Blood, 2012-05, Vol.119 (19), p.4543-4553

2012

Volltextzugriff (PDF)

Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project

Blood, 2017-04, Vol.129 (17), p.2368-2374

2017

Volltextzugriff (PDF)

Pharmacology in Childhood Arterial Ischemic Stroke

Seminars in pediatric neurology, 2010-12, Vol.17 (4), p.237-244

2010

Volltextzugriff (PDF)

Treatment of urgent bleeding in von Willebrand disease

Thrombosis research, 2007, Vol.120, p.S21-S25

Gill, Joan Cox

2007

Volltextzugriff (PDF)

The role of genetics in inhibitor formation

Thrombosis and haemostasis, 1999-08, Vol.82 (2), p.500

Gill, J C

1999

Volltextzugriff (PDF)

Thrombolysis in Pediatric Stroke Study

Stroke (1970), 2015-03, Vol.46 (3), p.880-885

2015

Volltextzugriff (PDF)

Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials

Blood transfusion = Trasfusione del sangue, 2013-10, Vol.11 (4), p.533-540

2013

Volltextzugriff (PDF)

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Blood, 2013-08, Vol.122 (5), p.648-657

2013

Volltextzugriff (PDF)

Variability in Bleeding Phenotype in Type 3 VWD Families

Blood, 2018-11, Vol.132 (Supplement 1), p.2466-2466

2018

Volltextzugriff (PDF)

Diagnosis of von Willebrand disease in people with type O blood

Clinical advances in hematology & oncology, 2014-02, Vol.12 (2), p.119-121

Gill, Joan Cox

2014

Volltextzugriff (PDF)

Emergence of the Primary Pediatric Stroke Center: Impact of the Thrombolysis in Pediatric Stroke Trial

Stroke (1970), 2014-07, Vol.45 (7), p.2018-2023

2014

Volltextzugriff (PDF)

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Blood, 2017-12, Vol.130, p.1085-1085

2017

Volltextzugriff (PDF)

Crucial role for the VWF A1 domain in binding to type IV collagen

Blood, 2015-04, Vol.125 (14), p.2297-2304

2015

Volltextzugriff (PDF)

Rate of never smokers in non small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19007-e19007

2015

Volltextzugriff (PDF)

Thromboembolic incidence with transiently elevated levels of coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surgery

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-11, Vol.20 (6), p.e404-e406

2014

Volltextzugriff (PDF)

CD4 + T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs

Future virology, 2013-07, Vol.8 (7), p.695-705

2013

Volltextzugriff (PDF)

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival

Blood, 2006-11, Vol.108 (10), p.3344-3351

2006

Volltextzugriff (PDF)

Impact of palliative care consults on racial disparity in do-not resuscitation (DNR) orders at an urban safety net hospital

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10027-10027

2018

Volltextzugriff (PDF)

1 – 25 von 424

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(363)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(169)
Humans
(139)
Female
(77)
Male
(73)
Biological And Medical Sciences
(59)
Medical Sciences
(46)
Adult
(42)
Middle Aged
(38)
Adolescent
(36)
Hematology
(33)
Child
(30)
Animals
(29)
Aged
(23)
Child, Preschool
(20)
Social Sciences
(19)
Biochemistry & Molecular Biology
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Mice
(15)
Pediatrics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

A cross-sectional analysis of cardiovascular disease in the hemophilia population

Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage

Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project

Pharmacology in Childhood Arterial Ischemic Stroke

Treatment of urgent bleeding in von Willebrand disease

The role of genetics in inhibitor formation

Thrombolysis in Pediatric Stroke Study

Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Variability in Bleeding Phenotype in Type 3 VWD Families

Diagnosis of von Willebrand disease in people with type O blood

Emergence of the Primary Pediatric Stroke Center: Impact of the Thrombolysis in Pediatric Stroke Trial

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Crucial role for the VWF A1 domain in binding to type IV collagen

Rate of never smokers in non small cell lung cancer (NSCLC) patients

Thromboembolic incidence with transiently elevated levels of coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surgery

CD4 + T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival

Impact of palliative care consults on racial disparity in do-not resuscitation (DNR) orders at an urban safety net hospital

Suchergebnisse filtern